Effect of Repeated Use of Progestagen-PMSG Treatment for Estrus Control in Dairy Goats out of Breeding Season

Possible effects of repeated hormonal treatments and laparoscopic ovum pick-up (LOPU) on the efficiency of oocyte recovery rate and quality were determined in sheep and goats. In six adult Merino sheep and five Criolla goats, ovarian status was synchronized by a prostaglandin F(2 alpha) analogue and the insertion of an intravaginal sponge 48 h later. Follicle development was stimulated by a single dose of FSH (60 mg NIH-FSH-P1) plus a single dose of equine chorionic gonadotrophin (eCG; 300 UI). The first FSH/eCG doses were administered 48 h after the sponge insertion, being repeated every 4 days to complete a total of four treatments in sheep and three in goats. Follicles in both ovaries were categorized according to their diameter and follicular fluid was aspirated under laparoscopic observation without a vacuum pump. In sheep, during a 12-day-period, a total of 347 follicles were aspirated with a recovery rate of 46.9%. In goats, during an 8-day-period, 219 follicles were aspirated with a recovery rate of 45.6%. In both species, there were no significant differences in the number of aspirated follicles, oocyte recovery rate and good quality oocyte recovery rate. However, in sheep the oocyte recovery rate was higher for large follicles, whereas in goats no such effect was detected. In summary, current results indicate that retrieval of oocytes can be maximized, without affecting oocyte quality, by repeating 'oneshot' FSH/eCG regimes and LOPUs at intervals as short as 4 days.

Section: Discussioncontrasting

confidence: 65%

Procedure for Maximizing Oocyte Harvest for In Vitro Embryo Production in Small Ruminants

Gibbons

Bonnet

Cueto

et al. 2007

“…The treatment would avoid the deleterious effect of the anti‐eCG antibodies produced when eCG is given repeatedly in the same herd. This is a common finding in some intensive goat breeding programmes where the pregnancy rate falls to 25–30% (Baril et al. 1992).…”

Section: Discussionmentioning

confidence: 88%

“…Moreover, the use of eCG after progestogen exposure to promote ovulatory follicular growth and ovulation is inquired as repeated eCG treatment is known to affect pregnancy rate in goats (Baril et al. 1992, 1996; Roy et al.…”

Section: Introductionmentioning

confidence: 99%

Pregnancy Rate Obtained with Short‐term Protocol for Timed Artificial Insemination in Goats

Menchaca¹,

Rubianes

2007

Recent studies demonstrated that the Short-term Protocol of 5 days of progestogen treatment plus one dose of prostaglandin F(2alpha) and equine chorionic gonadotrophin (eCG) resulted in a close synchronized ovulation (60 h after the end of treatment approximately). In addition, oestradiol benzoate (ODB) is effective in synchronizing ovulation in goats and could be an alternative to eCG. This study was performed to determine the pregnancy rate using the Short-term Protocol comparing: (i) two different moments of timed artificial insemination (TAI) after eCG treatment (trial 1) and (ii) ODB as an alternative to eCG treatment (trial 2). In trial 1, 250 IU of eCG was given at the end of progestogen exposure, and cervical TAI with fresh semen was performed 48 h (n = 156) or 54 h (n = 168) later. In trial 2, 250 IU of eCG was given at sponge withdrawal (eCG group, n = 154) or 200 mug of ODB was given 24 h later (ODB group, n = 119). TAI was performed 54 h after the end of progestogen treatment. Pregnancy rate was determined by transrectal ultrasonography. In trial 1, the pregnancy rate for goats with TAI performed at 54 h (107/168, 63.7%) was higher than for those with TAI performed 48 h (77/156, 49.4%; p < 0.05) after sponge withdrawal. In trial 2, pregnancy rate was higher in eCG (94/154, 61.0%) than in ODB (49/119, 40.3%; p < 0.05) treated goats. In conclusion, the highest pregnancy rate was achieved using Short-term Protocol associated with eCG and TAI performed 54 h after treatment.

“…Pregnant mare serum gonadotrophin (PMSG), also known as equine chronic gonadotropin, is a glycoprotein with activity similar to that of both luteinizing hormone (LH) and follicle‐stimulating hormone (FSH) (Combelles & Albertini, ). Its accessibility, low cost of production and lack of species specificity render PMSG widely usable for promoting follicular growth and regulating ovulation in livestock (Baril, Remy, Vallet, & Beckers, ; Forcada et al, ). However, PMSG is potentially immunogenic owing to its heterologous origin, large molecular size and long half‐life (Drion et al, ).…”

Section: Introductionmentioning

confidence: 99%

Repeated pregnant mare serum gonadotropin‐mediated oestrous synchronization alters gene expression in the ovaries and reduces reproductive performance in dairy goats

Sun

Luo

et al. 2019

Contents This study aimed to elucidate the effects of repeated pregnant mare serum gonadotropin (PMSG) treatment for oestrous synchronization (ES) on ovarian gene expression and reproductive parameters in Xinong Saanen dairy goats, the dominant breed of dairy goat in China. The experiment was carried out at the Research Station of Northwest A&F University (NWAFU), China (34°16′N, 108°4′E). Forty‐one does were randomly assigned to groups receiving ES treatments thrice every fortnight (3‐PMSG group; n = 19), or ES treatment only once simultaneously with the third ES treatment in the 3‐PMSG group (1‐PMSG group; n = 22) during middle of the breeding season from late July (14 hr light) until late September (12 hr light). ES treatment was performed via intravaginal insertion of a controlled internal drug release (CIDR) device impregnated with 300 mg progesterone (P4), followed by 300 IU PMSG injections 48 hr before CIDR withdrawal. Oestrus was monitored using vasectomized bucks. Ovaries of three goats in oestrus from both groups were harvested for morphological examination and RNA sequencing (RNA‐Seq). Then, all the oestrous goats in the 1‐PMSG (n = 21) and 3‐PMSG (n = 11) groups were artificially inseminated twice. The 3‐PMSG group showed reduced oestrous rate (57.89%), pregnancy rate (31.58%) and litter size (1.17) compared, respectively, with 95.45%, 68.18% and 1.67 for 1‐PMSG group (p < 0.05). However, no differences were found in the ovarian morphology between the 1‐PMSG and 3‐PMSG groups (p > 0.05). RNA‐Seq revealed 114 differentially expressed genes (DEGs) in the ovaries of the 3‐PMSG group, among which GCG, FSTL3, TET3 and AQP3 were deemed novel and promising candidate genes for regulating fertility. The present study indicates that the three‐time PMSG treatment dysregulated several ovarian genes, thereby reducing reproductive performance.